relapsed, refractory, multiple myeloma
Showing 1 - 1 of 1
Relapsed, Refractory, Multiple Myeloma Trial in Guangzhou (Pomalidomide, Bendamustine, Dexamethasone)
Not yet recruiting
- Relapsed, Refractory, Multiple Myeloma
- Pomalidomide
- +2 more
-
Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
Feb 17, 2021